Related Experiment Videos
[Acute meningococcal disease. Study of auditive sequelae].
J A Bermúdez de la Vega1, A Póstigo Madueño, A M Ruiz Carmona
1Cátedra de Pediatría y Puericultura, Facultad de Medicina, Hospital Universitario Virgen Macarena, Sevilla.
Anales Espanoles De Pediatria
|November 1, 1992
Summary
Children surviving acute meningococcal disease (AMD) showed no hearing loss. Early antibiotic treatment may minimize the risk of neurosensory hearing impairment in these patients.
Area of Science:
- Otolaryngology
- Pediatrics
- Infectious Diseases
Context:
- Acute meningococcal disease (AMD) can pose risks to survivors.
- Auditory function assessment is crucial for children post-AMD.
- Previous studies have indicated potential hearing deficits in AMD survivors.
Purpose:
- To evaluate the auditory function in children who have recovered from acute meningococcal disease.
- To identify any neurosensory or conductive hearing impairments resulting from AMD.
- To assess the long-term impact of AMD on hearing and the effectiveness of early interventions.
Summary:
- Auditory function was assessed in 49 children post-AMD using ABR, audiometry, and impedanciometry.
- Follow-up tests were conducted at 3 months for re-evaluation.
- No auditory impairments, including neurosensory hearing loss, were detected in the study cohort.
- The absence of hearing impairment was noted despite the presence of risk factors.
Impact:
- The findings suggest that early antibiotic treatment for AMD may significantly reduce the risk of hearing impairment.
- This study highlights the importance of prompt medical intervention in preventing long-term sequelae of meningococcal disease.
- Results support the implementation of early treatment protocols to safeguard auditory health in pediatric patients with AMD.